Clinical Study
Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
Table 2
Antibiotic resistance for E. coli isolated in blood cultures.
| Antibiotic resistance (%) | Regimen 1 () | Regime 2 () | Total () |
| Amoxicillin | 3 (60%) | 3 (75%) | 6 (67%) | Coamoxiclav | 1 (20%) | 2 (50%) | 3 (33%) | Ofloxacin | 4 (80%) | 1 (25%) | 5 (56%) | Gentamicin | 2 (40%) | 1 (25%) | 3 (33%) | Amikacin | 2 (40%) | 0 (0%) | 2 (22%) | 3rd-generation cephalosporinยง | 0 (0%) | 0 (0%) | 0 (0%) | Piperacillin/Tazobactam | 0 (0%) | 0 (0%) | 0 (0%) | Meropenem | 0 (0%) | 0 (0%) | 0 (0%) |
|
|
ยง3rd-generation cephalosporin either ceftriaxone or cefotaxime.
|